Q-omics provides the consensus-scored RNA5SP422 profile across patient tissues and cancer cell-line models. RNA5SP422 expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in UCS. Additionally, RNA5SP422 RNA expression shows 6,575 significant mutation-linked associations, with the highest sampling consensus in UCEC. Together, these results highlight UCS, and UCEC as cancer lineages where RNA5SP422 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.